Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily.
Phase of Trial: Phase IV
Latest Information Update: 25 Sep 2013
At a glance
- Drugs Trospium chloride (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Allergan
- 11 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Aug 2011 Planned end date changed from 1 Jun 2011 to 1 Jan 2013 as reported by ClinicalTrials.gov.
- 22 Mar 2010 New trial record